Tel'aran'rhiod” uses the world of dreams to explore the fears, growth, and limitations of The Wheel of Time’s characters.

Tarkir Dragonstorm promises to make dragon typal decks viable in Magic the Gathering’s standard format, driving demand for ...

In this atmosphere, the trial for the death of Diego Armando Maradona began on Tuesday, after two suspensions and more than four years since his passing. The process seeks to determine whether a ...

Lori Vallow Daybell will face trial in Arizona for conspiracy to commit murder in the 2019 death of her ex-husband, Charles Vallow. Jury selection was likely to begin March 31, with opening ...

As the trial of missing six-year-old Joshlin Smith enters its seventh day, new witnesses from the Saldanha Bay community are set to testify about their experiences following her disappearance.

"Obviously, he lost his wife and so his life is still sort of ruined, and he still has another potential trial to field ahead." Ferguson remains free on $2 million bail pending future court ...

Stage 3 of Paris-Nice offers up a team time trial, as has become a traditional mid-week fixture in the French stage race. Tuesday's effort is 28.4km long across fairly rolling terrain between ...

Produced by ElevenLabs and News Over Audio (Noa) using AI narration. Listen to more stories on the Noa app. Khalil, a legal permanent resident of the United States and Palestinian activist who ...

Visma-Lease a Bike powered to victory in the stage 3 team time trial in Paris-Nice, moving defending champion Matteo Jorgenson into the yellow jersey. The Dutch team beat Jayco-AlUla by 14 seconds ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

A jury on Monday sided with Disney in a copyright trial involving “Moana,” clearing the company of an infringement suit brought by a screenwriter. The plaintiff, Buck Woodall, filed suit in ...

LONDON/COPENHAGEN, March 10 (Reuters) - Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and ...